
Eliminate unnecessary animal studies, establish clear conditions for comparative clinical trials, say healthcare advocates
There is an urgent need to eliminate unnecessary animal studies, and establish clear conditions for requiring comparative clinical trials for affordable biosimilars without compromising safety




